Robyn J. Levy

3.1k citations

37 papers · 1.6k indexed · h-index 19

Co-authors: H. Henry Li Timothy Craig Marco Cicardi William E. Pullman Patrick T. Horn Marilyn Campion Richard L. Wasserman Dumitru Moldovan
Topics: Coagulation, Bradykinin, Polyphosphates, and Angioedema (29 papers)Mast cells and histamine (9 papers)Autoimmune Bullous Skin Diseases (9 papers)
Cited by: Genetics Hematology Rheumatology
Journals: New England Journal of Medicine The American Journal of Medicine Journal of Allergy and Clinical Immunology
Partner nations: United States Romania Israel

In The Last Decade

Robyn J. Levy

37 papers receiving 1.6k citations

Peers

Countries citing papers authored by Robyn J. Levy

Since Specialization

Citations

This map shows the geographic impact of Robyn J. Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robyn J. Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robyn J. Levy more than expected).

Fields of papers citing papers by Robyn J. Levy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robyn J. Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robyn J. Levy. The network helps show where Robyn J. Levy may publish in the future.

Co-authorship network of co-authors of Robyn J. Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Robyn J. Levy. A scholar is included among the top collaborators of Robyn J. Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robyn J. Levy. Robyn J. Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy, Safety, and Pharmacokinetics of a New 10 % Liquid Intravenous Immunoglobulin Containing High Titer Neutralizing Antibody to RSV and Other Respiratory Viruses in Subjects with Primary Immunodeficiency Disease 2016 ·Journal of Clinical Immunology ·Richard L. Wasserman,William R. Lumry,James B. Harris,Robyn J. Levy,Mark R. Stein,Lisa R. Forbes,Charlotte Cunningham‐Rundles,Isaac Melamed,Ai Kobayashi,Wei Du,Roger H. Kobayashi	23
2	Recombinant Human-C1 Inhibitor Is Effective and Safe for Repeat Hereditary Angioedema Attacks 2015 ·The Journal of Allergy and Clinical Immunology In Practice ·H. Henry Li,Dumitru Moldovan,Jonathan A. Bernstein,Avner Reshef,Grzegorz Porębski,Marcin Stobiecki,James Baker,Robyn J. Levy,Anurag Relan,Marc A. Riedl	30
3	Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial 2014 ·Annals of Allergy Asthma & Immunology ·Marc A. Riedl,Jonathan A. Bernstein,Henry Li,Avner Reshef,William R. Lumry,Dumitru Moldovan,Henriette Farkas,Robyn J. Levy,James Baker,(unknown),Mark C. Totoritis,Anurag Relan,Marco Cicardi	60
4	Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study 2013 ·Annals of Allergy Asthma & Immunology ·Marc A. Riedl,Robyn J. Levy,Daniel Suez,Richard F. Lockey,James Baker,Anurag Relan,Bruce L. Zuraw	42
5	Clinical Impact of Peripheral Attacks in Hereditary Angioedema Patients 2012 ·The American Journal of Medicine ·(unknown),Anurag Relan,André C. Knulst,Dumitru Moldovan,Bruce L. Zuraw,Marco Cicardi,Robyn J. Levy,Jan H. Nuijens,C. Erik Hack	19
6	Per-Attack Reporting of Prodromal Symptoms Concurrent with C1-Inhibitor Treatment of Hereditary Angioedema Attacks 2012 ·Advances in Therapy ·(unknown),Againdra K. Bewtra,Robyn J. Levy,Richard L. Wasserman,Kraig W. Jacobson,Thomas Machnig,Timothy Craig	24
7	Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Subcutaneous (SC) Cinryze® (C1 inhibitor (C1 INH) with Recombinant Human Hyaluronidase (rHuPH20) in Subjects with Hereditary Angioedema (HAE) 2012 ·Journal of Allergy and Clinical Immunology ·Jennifer Schranz,Robyn J. Levy,William R. Lumry,Michael Manning,Joshua Jacobs,Samuel S. Dychter,Michael J. LaBarre,A. Phillips,Steven P Gelone,Colin Broom	4
8	Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial 2011 ·Annals of Allergy Asthma & Immunology ·William R. Lumry,H. Henry Li,Robyn J. Levy,Paul C. Potter,Henriette Farkas,Dumitru Moldovan,Marc A. Riedl,Hongbin Li,Timothy Craig,Bradley J. Bloom,Avner Reshef	178
9	Ecallantide (DX-88) for acute hereditary angioedema attacks: Integrated analysis of 2 double-blind, phase 3 studies 2011 ·Journal of Allergy and Clinical Immunology ·Albert L. Sheffer,Marilyn Campion,Robyn J. Levy,H. Henry Li,Patrick T. Horn,William E. Pullman	49
10	Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: an open-label trial 2011 ·Annals of Allergy Asthma & Immunology ·Marc A. Riedl,David Hurewitz,Robyn J. Levy,Paula J. Busse,David Fitts,Ira N. Kalfus	24
11	C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks - final results of the I.M.P.A.C.T.2 study 2011 ·Allergy ·Timothy Craig,Againdra K. Bewtra,Sami L. Bahna,David Hurewitz,Lynda C. Schneider,Robyn J. Levy,James N. Moy,J. Offenberger,Kraig W. Jacobson,W.H. Yang,F. Eidelman,(unknown),(unknown),Mikhail Rojavin,Thomas Machnig,Heinz-Otto Keinecke,Richard L. Wasserman	104
12	Results From FAST-3: A Phase III Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Subcutaneous Icatibant in Patients with Acute Hereditary Angioedema (HAE) Attacks 2011 ·Journal of Allergy and Clinical Immunology ·William R. Lumry,(unknown),Robyn J. Levy,Paul C. Potter,Henriette Farkas,Avner Reshef,Dumitru Moldovan,Marc A. Riedl,(unknown),Bradley J. Bloom	10
13	Ecallantide for the Treatment of Acute Attacks in Hereditary Angioedema 2010 ·New England Journal of Medicine ·Marco Cicardi,Robyn J. Levy,Donald McNeil,H. Henry Li,Albert L. Sheffer,Marilyn Campion,Patrick T. Horn,William E. Pullman	234
14	EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema 2010 ·Annals of Allergy Asthma & Immunology ·Robyn J. Levy,William R. Lumry,Donald McNeil,H. Henry Li,Marilyn Campion,Patrick T. Horn,William E. Pullman	116
15	Prospective Study of Rapid Relief Provided by C1 Esterase Inhibitor in Emergency Treatment of Acute Laryngeal Attacks in Hereditary Angioedema 2010 ·Journal of Clinical Immunology ·Timothy Craig,Richard L. Wasserman,Robyn J. Levy,Againdra K. Bewtra,Lynda C. Schneider,(unknown),William H. Yang,(unknown),Peter Kießling	37
16	Prospective study of C1 esterase inhibitor in the treatment of successive acute abdominal and facial hereditary angioedema attacks 2010 ·Annals of Allergy Asthma & Immunology ·Richard L. Wasserman,Robyn J. Levy,Againdra K. Bewtra,David Hurewitz,Timothy Craig,Peter Kießling,(unknown),Jonathan A. Bernstein	13
17	Population pharmacokinetics of plasma-derived C1 esterase inhibitor concentrate used to treat acute hereditary angioedema attacks 2010 ·Annals of Allergy Asthma & Immunology ·Jonathan A. Bernstein,Bruce Ritchie,Robyn J. Levy,Richard L. Wasserman,Againdra K. Bewtra,David Hurewitz,Krystyna Obtułowicz,Avner Reshef,Dumitru Moldovan,(unknown),Vesna Grivcheva‐Panovska,Peter Kießling,F. Schindel,Timothy Craig	24
18	Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema 2010 ·Journal of Allergy and Clinical Immunology ·Bruce L. Zuraw,Marco Cicardi,Robyn J. Levy,Jan H. Nuijens,Anurag Relan,Sonja Visscher,Gerald M. Haase,Leonard Kaufman,C. Erik Hack	174
19	Safety and Efficacy in Children with Persistent Asthma Treated with Formoterol 10 µg BID Delivered via Certihaler ^™ : A Novel Multidose Dry-Powder Inhaler 2005 ·Pediatric Asthma Allergy & Immunology ·Robyn J. Levy,Jacob L. Pinnas,Henry Milgrom,Jonathan A. Smith,(unknown)	10
20	Treatment of Status Epilepticus With Lorazepam 1984 ·Archives of Neurology ·Robyn J. Levy,Ronald L Krall	39

About Robyn J. Levy

Robyn J. Levy is a scholar working on Genetics, Hematology and Immunology, having authored 37 papers that have together received 1.6k indexed citations. Recurring topics across this work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (29 papers), Mast cells and histamine (9 papers) and Autoimmune Bullous Skin Diseases (9 papers). The work is most often cited by research in Genetics (1.4k citations), Hematology (521 citations) and Rheumatology (580 citations). Robyn J. Levy has collaborated with scholars based in United States, Romania and Israel. Frequent co-authors include H. Henry Li, Timothy Craig, Marco Cicardi, William E. Pullman, Patrick T. Horn, Marilyn Campion, Richard L. Wasserman, Dumitru Moldovan, Donald McNeil and Avner Reshef. Their work appears in journals such as New England Journal of Medicine, The American Journal of Medicine and Journal of Allergy and Clinical Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact